Dietary ethanolamine and phosphoethanolamine phospholyase (ETNPPL) as novel modulators of liver health

膳食乙醇胺和磷酸乙醇胺磷酸解酶（ETNPPL）作为肝脏健康的新型调节剂

• 批准号: 437588
• 负责人: Jacobs Rene L
• 金额: $ 7.29万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=437588&lang=en
• 关键词: Diet-Gene Interaction; Lipids; Liver; Nutrition

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be 25%, which means that over 8 million Canadians suffer from this disease. Increased understanding of the development and progression of NAFLD is crucially important for the deve

非酒精性脂肪肝（NAFLD）的患病率估计为25%，这意味着超过800万加拿大人患有这种疾病。增加对NAFLD的发展和进展的了解对于NAFLD的发展至关重要。